53 related articles for article (PubMed ID: 19797015)
1. Age and prevalence of cervical carcinoma in subsequent hysterectomy following a conization procedure.
Wun TH; Chiu WW; Wang CB; Tseng CC; Chen CH; Lin YH; Lee CY; Sun YL; Tseng CJ
Taiwan J Obstet Gynecol; 2009 Sep; 48(3):254-7. PubMed ID: 19797015
[TBL] [Abstract][Full Text] [Related]
2. Age and prevalence of cervical carcinoma in subsequent hysterectomy following a conization procedure questioned.
Tsai HJ
Taiwan J Obstet Gynecol; 2010 Sep; 49(3):394. PubMed ID: 21056337
[No Abstract] [Full Text] [Related]
3. Risk for residual adenocarcinoma in situ or cervical adenocarcinoma in women undergoing loop electrosurgical excision procedure/conization for adenocarcinoma in situ.
DeSimone CP; Day ME; Dietrich CS; Tovar MM; Modesitt SC
J Reprod Med; 2011; 56(9-10):376-80. PubMed ID: 22010519
[TBL] [Abstract][Full Text] [Related]
4. [Risk factors of predicting residual disease in women with stage I a1 squamous cervical carcinoma after conization].
Zhu XE; Feng Y; Fu YF; Cheng XD; Chen XD; Xie X; Lü WG
Zhonghua Yi Xue Za Zhi; 2013 Feb; 93(7):534-6. PubMed ID: 23660325
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and risk factors for residual cervical neoplasia in subsequent hysterectomy following LEEP or conization.
Natee J; Therasakvichaya S; Boriboonhirunsarn D
J Med Assoc Thai; 2005 Oct; 88(10):1344-8. PubMed ID: 16519377
[TBL] [Abstract][Full Text] [Related]
6. Re: "Pathologic risk factors for predicting residual disease in subsequent hysterectomy following LEEP conization".
Verguts J; Schockaert S; Moerman P; Poppe W
Gynecol Oncol; 2007 Jul; 106(1):273. PubMed ID: 17477960
[No Abstract] [Full Text] [Related]
7. Unexpected tumor progression after conization for carcinoma in situ of the uterine cervix.
Omatsu K; Takeshima N; Matoda M; Nomura H; Umayahara K; Sugiyama Y; Utsugi K; Tanaka H; Akiyama F; Takizawa K
J Obstet Gynaecol Res; 2012 Jan; 38(1):84-8. PubMed ID: 21917067
[TBL] [Abstract][Full Text] [Related]
8. Outpatient loop electrosurgical excision procedure for cervical intraepithelial neoplasia. Can it replace cold knife conization?
Eduardo AM; Dinh TV; Hannigan EV; Yandell RB; Schnadig VJ
J Reprod Med; 1996 Oct; 41(10):729-32. PubMed ID: 8913973
[TBL] [Abstract][Full Text] [Related]
9. Prediction of residual neoplasia based on histopathology and margin status of conization specimens.
Chang DY; Cheng WF; Torng PL; Chen RJ; Huang SC
Gynecol Oncol; 1996 Oct; 63(1):53-6. PubMed ID: 8898168
[TBL] [Abstract][Full Text] [Related]
10. Adenocarcinoma in situ of the uterine cervix: management and outcome.
Widrich T; Kennedy AW; Myers TM; Hart WR; Wirth S
Gynecol Oncol; 1996 Jun; 61(3):304-8. PubMed ID: 8641606
[TBL] [Abstract][Full Text] [Related]
11. A study of diagnostic failure of loop conization in microinvasive carcinoma of the cervix.
Tseng CJ; Liang CC; Lin CT; Huang KG; Chou HH; Chang TC; Lai CH; Soong YK; Hsueh S
Gynecol Oncol; 1999 Apr; 73(1):91-5. PubMed ID: 10094886
[TBL] [Abstract][Full Text] [Related]
12. Evaluating cervical neoplasia. LEEP as an alternative to cold knife conization.
Simmons JR; Anderson L; Hernandez E; Heller PB
J Reprod Med; 1998 Dec; 43(12):1007-13. PubMed ID: 9883402
[TBL] [Abstract][Full Text] [Related]
13. Adenocarcinoma in situ of the uterine cervix.
Muntz HG; Bell DA; Lage JM; Goff BA; Feldman S; Rice LW
Obstet Gynecol; 1992 Dec; 80(6):935-9. PubMed ID: 1448263
[TBL] [Abstract][Full Text] [Related]
14. Conservative management of adenocarcinoma in situ of the cervix.
Shin CH; Schorge JO; Lee KR; Sheets EE
Gynecol Oncol; 2000 Oct; 79(1):6-10. PubMed ID: 11006022
[TBL] [Abstract][Full Text] [Related]
15. [Organ-saving and function-conserving procedures in the treatment of cervical carcinoma].
Novikova EG; Antipov VA; Ronina EA; Rubtsova NA
Vopr Onkol; 2006; 52(1):78-82. PubMed ID: 16715710
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic features of early adenocarcinoma of the cervix initially managed with cervical conization.
Poynor EA; Marshall D; Sonoda Y; Slomovitz BM; Barakat RR; Soslow RA
Gynecol Oncol; 2006 Dec; 103(3):960-5. PubMed ID: 16860853
[TBL] [Abstract][Full Text] [Related]
17. Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix.
Poynor EA; Barakat RR; Hoskins WJ
Gynecol Oncol; 1995 May; 57(2):158-64. PubMed ID: 7729727
[TBL] [Abstract][Full Text] [Related]
18. The value of MR-based radiomics in identifying residual disease in patients with carcinoma in situ after cervical conization.
Song M; Lin J; Song F; Wu D; Qian Z
Sci Rep; 2020 Nov; 10(1):19890. PubMed ID: 33199785
[TBL] [Abstract][Full Text] [Related]
19. Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix.
Denehy TR; Gregori CA; Breen JL
Obstet Gynecol; 1997 Jul; 90(1):1-6. PubMed ID: 9207802
[TBL] [Abstract][Full Text] [Related]
20. Fertility-sparing surgery in 101 women with adenocarcinoma in situ of the cervix.
Bull-Phelps SL; Garner EI; Walsh CS; Gehrig PA; Miller DS; Schorge JO
Gynecol Oncol; 2007 Nov; 107(2):316-9. PubMed ID: 17689593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
